SS
ACIU icon

SBI Securities’s AC Immune ACIU Stock Holding History

SBI Securities’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.85K Buy
+1,197
New +$3.3K ﹤0.01% 2425
2026
Q1 		– Sell
-547
Closed -$1.72K – 4012
2025
Q4 		$1.72K Sell
547
-1
-0.2% -$3 ﹤0.01% 2446
2025
Q3 		$1.58K Sell
548
-17
-3% -$38 ﹤0.01% 2514
2025
Q2 		$1.15K Buy
565
+4
+0.7% +$7 ﹤0.01% 2621
2025
Q1 		$1.05K Buy
561
+17
+3% +$43 ﹤0.01% 2561
2024
Q4 		$1.47K Buy
+544
New +$1.7K ﹤0.01% 2433

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

SBI Securities's ACIU Position: Q2 2026 in Review

SBI Securities opened a new position in AC Immune (ACIU) in Q2 2026: 1,197 shares worth $2.85K. The stake represents ﹤0.01% of the portfolio and ranks #2425 among its holdings. This is a return to the name: SBI Securities previously reported a position in ACIU as recently as Q4 2025.

SBI Securities first reported a position in ACIU in Q4 2024 and has held it in 6 quarters since. 43 funds tracked by Wall St. Rank hold ACIU as of Q2 2026.

  • SBI Securities held 1,197 shares of AC Immune worth $2.85K as of Q2 2026.
  • AC Immune was a new SBI Securities position in Q2 2026.
  • AC Immune made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2425 holding.
  • SBI Securities first reported a position in AC Immune in Q4 2024 and has held it in 6 quarters since.
  • 43 funds tracked by Wall St. Rank held AC Immune as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.